" /> Therapeutic Liver Cancer Peptide Vaccine IMA970A - CISMeF





Preferred Label : Therapeutic Liver Cancer Peptide Vaccine IMA970A;

NCIt synonyms : HCC Vaccine IMA970A;

NCIt definition : An off-the-shelf hepatocellular cancer (HCC) multi-peptide-based therapeutic vaccine composed of sixteen peptides derived from tumor-associated antigens (TAAs) expressed by hepatic tumor cells, of which seven are restricted to human leukocyte antigen (HLA)-A2 (HLA-A*02), five to HLA-A*24 and four to HLA class II, with potential immunomodulating and antineoplastic activities. Upon intradermal administration of the therapeutic liver cancer peptide vaccine IMA970A, the liver-specific peptides in the vaccine activate the immune system to exert both CD4 T-helper and CD8 cytotoxic T-lymphocyte (CTL)-mediated immune responses against liver cancer cells.;

Molecule name : IMA970A;

NCI Metathesaurus CUI : CL553170;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.